Loading company…
Motley Bio uses multiomics research to study disease biology and support precision medicine.
Based in California, Motley Bio applies genomics, proteomics, and metabolomics to study disease mechanisms and identify biomarkers. It serves pharmaceutical companies, academic institutions, and healthcare providers. The company generates revenue through research service contracts and collaborations. In December 2024, it raised venture funding from Atlas.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in